Conflicts of interest/Competing interests
GS, Cancer
ONCOLOGY, CANCER, EMD
J Chmielecki, ER Imedio, S Kumar, S Jenkins and G Mugundu are employees and shareholders of AstraZeneca plc. GS Falchook, M Johnson, S Jones and DR Spigel are employees of Sarah Cannon Research Institute. J Sachdev is an employee of HonorHealth Research Institute. GS Falchook has received speaking fees from Total Health Conferencing and Rocky Mountain Oncology Society; royalties from Wolters Kluwer; travel expenses from Bristol-Myers Squibb, EMD Serono, Fujifilm, Millennium, and Sarah Cannon Research Institute; and research funding from 3-V Biosciences, Abbisko, AbbVie, ADC Therapeutics, Aileron, American Society of Clinical Oncology, Amgen, ARMO/Eli Lilly, AstraZeneca, BeiGene, Bioatla, Bioinvent, Biothera, Bicycle, Celldex, Celgene, Ciclomed, Curegenix, Curis, Cyteir, Daiichi, DelMar, eFFECTOR, Eli Lilly, EMD Serono, Epizyme, Exelixis, Fujifilm, Genmab, GlaxoSmithKline, Hutchison MediPharma, IGM Biosciences, Ignyta, ImmunoGen/MacroGenics, Incyte Corporation, Jacobio, Jounce, Kolltan, Loxo/Bayer, MedImmune, Millennium, Merck, miRNA Therapeutics, National Institutes of Health, Navire, Novartis, OncoMed, Oncorus, Oncothyreon, Poseida, Precision Oncology, Prelude, PureTech, Regeneron, Rgenix, Ribon, Sapience, Silicon, Strategia, Syndax, Synthorx/Sanofi, Taiho, Takeda, Tarveda, Tesaro, Tocagen, Turning Point Therapeutics, University of Texas MD Anderson Cancer Center, Vegenics, and Xencor and has served in an advisory role for Fujifilm, Silicon, Navire, and EMD Serono.